tiprankstipranks
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Income Statement

Compare
1,400 Followers

Beam Therapeutics Income Statement

Last quarter (Q4 2024), Beam Therapeutics's total revenue was $30.07M, a decrease of -90.49% from the same quarter last year. In Q4, Beam Therapeutics's net income was $-90.35M. See Beam Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 63.52M$ 377.71M$ 60.92M$ 51.84M$ 24.00K
Gross Profit
$ 63.52M$ -59.67M$ 38.34M$ 35.40M$ -103.16M
Operating Expenses
$ 479.09M$ 554.19M$ 399.40M$ 444.31M$ 132.78M
Depreciation and Amortization
$ 0.00$ 20.01M$ 22.58M$ 16.44M$ 9.47M
EBITDA
$ -415.57M$ -156.47M$ -324.33M$ -392.46M$ -128.03M
Operating Income
$ -415.57M$ -176.49M$ -338.48M$ -392.46M$ -132.76M
Other Income/Expenses
$ 38.87M$ 45.32M$ 78.30M$ 21.83M$ -61.83M
Pretax Income
$ -376.70M$ -131.16M$ -260.18M$ -370.64M$ -194.59M
Net Income
$ -376.74M$ -132.53M$ -263.59M$ -341.36M$ -256.42M
Per Share Metrics
Basic EPS
$ -4.58$ -1.72$ -3.76$ -5.31$ -5.49
Diluted EPS
$ -4.58$ -1.72$ -3.76$ -5.31$ -5.49
Weighted Average Shares Outstanding
82.31M 77.15M 70.02M 64.23M 46.73M
Weighted Average Shares Outstanding (Diluted)
82.31M 77.15M 70.02M 64.23M 46.73M
Currency in USD

Beam Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis